| Registry | NCT07232342 |
|---|---|
| Status | Completed |
| Study type | Observational |
| Enrollment | 100 (Actual) |
| Sponsor | Benha University (Other) |
| Conditions | Peritonitis Infectious |
| Interventions | Capillary Leak Index Versus (Diagnostic test) |
| Dates | start 2025-12-10, primary completion 2026-10-01, completion 2026-10-15, first posted 2025-11-18, last updated 2026-10-20 |
| Locations | 1 site in Egypt |
Related Papers Related Patents Related Grants Related Experts
All trials for Peritonitis Infectious All trials of Capillary Leak Index Versus
This study aims to evaluate the prognostic significance of CLI in predicting 28-day mortality and other outcomes in critically ill patients who develop post-operative abdominal sepsis.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| adult patients admitted to the ICU with post-operative secondary peritonitis requiring an ICU stay o | Diagnostic Test: Capillary Leak Index Versus |
Sex: All, ages: 18 Years to any
Inclusion Criteria: Age ≥ 18 years. Postoperative secondary peritonitis requiring ICU admission, with clinical evidence of: Diffuse or localized abdominal pain/tenderness. Peritoneal signs (e.g., guarding, rigidity, rebound tenderness). Imaging or intraoperative confirmation of purulent/exudative intra-abdominal fluid. Systemic inflammation (e.g., fever, leukocytosis, or vasopressor requirement). Sepsis diagnosis per Sepsis-3 criteria: Suspected/confirmed infection with acute increase in SOFA score ≥2 points (6). Anticipated ICU stay ≥48 hours postoperatively. Exclusion Criteria: * Pregnancy * Advanced liver disease (Child-Pugh class B or C) that might independently affect albumin levels * Advanced kidney disease (CKD stage 4 or 5) or patients on chronic dialysis * Expected mortality within 48 hours of ICU admission * Patients with primary peritonitis or tertiary peritonitis * Immunocompromised patients (e.g., on chronic immunosuppressive therapy, solid organ transplant recipients, patients with HIV and CD4 count <200/mm³) * Patients with pre-existing systemic inflammatory diseases that might affect baseline CRP levels * Patients participating in interventional trials that might affect outcomes
| Facility | City | Country | Status |
|---|---|---|---|
| Benha University Hospital | Banhā, Qalyubia Governorate | Egypt |